Date prepared: 07\/07\/2022<\/p>\n\n\n\n
Abbreviated name of the issuer: CELON PHARMA S.A.<\/p>\n\n\n\n
Subject: Allocation of 5,000 C series shares under a conditional share capital increase Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<\/p>\n\n\n\n Content of the report:<\/p>\n\n\n\n The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby informs about the registration of 5,000 C series shares with a nominal value of PLN 0.10 each on the securities accounts of eligible persons, under a conditional share capital increase (\u201cShares\u201d). The shares have been acquired by holders of A series subscription warrants, the granting of which, under the Incentive Programs for Members of the Management Board and other persons of key importance to the Company, was announced by the Company in its current report No. 8\/2022 of April 15, 2022. To the best knowledge of the Company, the granting of the Shares took place on June 27, 2022, according to the statements of the persons eligible to acquire the Shares, after they had made contributions for the Shares in full, pursuant to Resolution No. 7\/2021 of the Extraordinary General Meeting of the Company of February 16, 2021 on the issue, for the purpose of implementing Incentive Programs for Members of the Management Board and other persons of key importance to the Company, of A series subscription warrants with exclusion of share subscription rights of existing shareholders, entitling them to subscribe for C series shares and a conditional increase of the share capital through the issue of C series shares with exclusion of share subscription rights of existing shareholders and an amendment to the Company’s Articles of Association related thereto.<\/p>\n\n\n\n Together with the granting of the Shares rights attached to Shares were acquired and the Company\u2019s share capital was increased by PLN 500. After the increase, the Company’s share capital is PLN 5,103,500 and is divided into 51,035,000 shares, including:<\/p>\n\n\n\n – 15,000,000 A1-series registered shares, privileged as to voting in such a way that each share carries two votes at the General Meeting of the Company,<\/p>\n\n\n\n – 15.000.000 ordinary A2-series bearer shares,<\/p>\n\n\n\n – 15.000.000 ordinary B-series bearer shares,<\/p>\n\n\n\n – 35.000 ordinary C-series bearer shares,<\/p>\n\n\n\n – 6.000.000 ordinary D-series bearer shares,<\/p>\n\n\n\n The total number of votes arising from all shares issued by the Company is 66,035,000.<\/p>\n\n\n\n The amount of the conditional increase in the share capital after the above-mentioned Shares have been granted is PLN 196.500.<\/p>\n\n\n\n Pursuant to Article 452 \u00a7 4 of the Commercial Companies Code, the Management Board of the Company shall submit a motion to the registration court to update the entry on the Company\u2019s share capital.<\/p>\n","protected":false},"excerpt":{"rendered":".<\/del><\/p>\n\n\n\n